Does DOFETILIDE Cause Mobility decreased? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Mobility decreased have been filed in association with DOFETILIDE (Dofetilide). This represents 0.2% of all adverse event reports for DOFETILIDE.
8
Reports of Mobility decreased with DOFETILIDE
0.2%
of all DOFETILIDE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Mobility decreased From DOFETILIDE?
Of the 8 reports, 2 (25.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOFETILIDE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does DOFETILIDE Cause?
Drug ineffective (654)
Atrial fibrillation (438)
Death (285)
Electrocardiogram qt prolonged (267)
Dyspnoea (230)
Dizziness (228)
Fatigue (180)
Malaise (175)
Headache (154)
Palpitations (128)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which DOFETILIDE Alternatives Have Lower Mobility decreased Risk?
DOFETILIDE vs DOLUTEGRAVIR
DOFETILIDE vs DOLUTEGRAVIR\LAMIVUDINE
DOFETILIDE vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL
DOFETILIDE vs DOLUTEGRAVIR\RILPIVIRINE
DOFETILIDE vs DOMPERIDONE